REGN | Regeneron Pharmaceuticals – Macro Reaccumulation SetupPublished by WaverVanir International LLC | 06/12/2025
Regeneron has completed a deep retracement, touching the 0.886 Fibonacci level (~$567) and entering a strong discount zone, coinciding with a weak low sweep and increasing volume — suggesting potential accumulation by institutions.
🔍 Key Confluences:
🔄 Internal CHoCH and BOS structure shift indicates short-term reversal
🔵 Entered macro discount territory with a clean sweep of liquidity below $485
🟡 Targeting major inefficiency and liquidity void around $766.75, aligning with 0.5 retracement and prior equilibrium
🟥 Supply zones between $640–$720 may offer resistance/partial profit-taking zones
📉 Risk Framework:
Entry consideration: $500–$520
Stop loss idea: Below $475 (invalidate weak low sweep)
Primary Target: $766.75
Secondary Target (Extended): $818–$852
🧠 Fundamental & Macro Watch:
Upcoming trial results or FDA action could act as a key catalyst
Biotech sector sentiment tied to macro healthcare policy and AI-integration for drug discovery
Recent earnings showed strong forward guidance – potential re-rating ahead
📈 Probabilistic Outlook:
Bullish retracement toward $766.75: 70%
Extended bearish continuation (below $485): 15%
Sideways chop: 15%
🧭 Smart money often reacts to extreme fear – REGN may be entering a mark-up phase if confirmed with institutional follow-through.
#REGN NASDAQ:REGN #SmartMoneyConcepts #FibConfluence #WaverVanir #BiotechStocks #SwingTrading #TechnicalAnalysis #InstitutionalOrderFlow
